trial · primary record
JNJ-78278343
Prostatic Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 140 |
| Primary completion | 2027-12-30 |
| Primary endpoint | Number of Participants With Adverse Events (AEs) by Severity |
| Registry ID | NCT07082920 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:47.106Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07082920
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-78278343 · compound